Tempest Therapeutics Inc (TPST)
3.18
-0.04
(-1.24%)
USD |
NASDAQ |
May 17, 16:00
3.18
0.00 (0.00%)
After-Hours: 20:00
Tempest Therapeutics Market Cap: 70.65M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 70.65M |
| May 16, 2024 | 71.54M |
| May 15, 2024 | 75.09M |
| May 14, 2024 | 75.54M |
| May 13, 2024 | 72.87M |
| May 10, 2024 | 72.21M |
| May 09, 2024 | 77.09M |
| May 08, 2024 | 77.09M |
| May 07, 2024 | 80.43M |
| May 06, 2024 | 82.87M |
| May 03, 2024 | 81.98M |
| May 02, 2024 | 78.65M |
| May 01, 2024 | 80.43M |
| April 30, 2024 | 77.09M |
| April 29, 2024 | 76.43M |
| April 26, 2024 | 78.65M |
| April 25, 2024 | 77.32M |
| April 24, 2024 | 76.43M |
| April 23, 2024 | 75.98M |
| April 22, 2024 | 71.98M |
| April 19, 2024 | 68.87M |
| April 18, 2024 | 70.43M |
| April 17, 2024 | 72.65M |
| April 16, 2024 | 74.43M |
| April 15, 2024 | 74.21M |
| Date | Value |
|---|---|
| April 12, 2024 | 79.76M |
| April 11, 2024 | 85.54M |
| April 10, 2024 | 82.65M |
| April 09, 2024 | 85.98M |
| April 08, 2024 | 88.65M |
| April 05, 2024 | 82.65M |
| April 04, 2024 | 99.98M |
| April 03, 2024 | 113.86M |
| April 02, 2024 | 113.09M |
| April 01, 2024 | 120.86M |
| March 28, 2024 | 86.77M |
| March 27, 2024 | 82.33M |
| March 26, 2024 | 82.33M |
| March 25, 2024 | 80.78M |
| March 22, 2024 | 80.78M |
| March 21, 2024 | 77.89M |
| March 20, 2024 | 83.44M |
| March 19, 2024 | 83.00M |
| March 18, 2024 | 85.88M |
| March 15, 2024 | 80.78M |
| March 14, 2024 | 76.12M |
| March 13, 2024 | 75.23M |
| March 12, 2024 | 74.51M |
| March 11, 2024 | 74.51M |
| March 08, 2024 | 74.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.294M
Minimum
Oct 09 2023
160.76M
Maximum
Jul 12 2021
44.24M
Average
25.69M
Median
Market Cap Benchmarks
| CEL-SCI Corp | 68.78M |
| AIM ImmunoTech Inc | 20.11M |
| IGC Pharma Inc | 35.69M |
| NovaBay Pharmaceuticals Inc | 4.487M |
| Protalix BioTherapeutics Inc | 83.58M |
Market Cap Related Metrics
| Price to Book Value | 3.424 |
| Price | 3.18 |
| Earnings Yield | -54.09% |